Patents by Inventor James Lawrence Burg

James Lawrence Burg has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20130157378
    Abstract: A device including a shallow chamber for analyzing a plurality of target analytes in a body fluid using the signal generated by fluorescent detector molecules each specific for a target analyte, an attenuating dye for attenuating the signal emitted by fluorescent detector molecules specifically bound to the surfaces of the chamber other than an optically clear surface, and method for determining the signal generated by each of the plurality of analytes.
    Type: Application
    Filed: December 15, 2011
    Publication date: June 20, 2013
    Inventor: James Lawrence Burg
  • Patent number: 6410276
    Abstract: A method is provided for multiplying the number of copies of a target polynucleotide sequence comprising a series of primer hybridization, extending, and denaturing steps to provide an intermediate double-stranded DNA molecule containing a promoter sequence (through the use of a promoter-sequence-containing primer) incorporated upstream from the target sequence. The double-stranded DNA intermediate is then used to grow multiple RNA copies of the target sequence. The resulting RNA copies can be used as target sequences to produce further copies. Multiple cycles of this sort can thereby exponentially increase the number of target sequence copies.
    Type: Grant
    Filed: April 24, 1995
    Date of Patent: June 25, 2002
    Assignee: The Board of Trustees of the Leland Stanford Junior University
    Inventors: James Lawrence Burg, Philippe Jacques Pouletty, John Charles Boothroyd
  • Patent number: 6090591
    Abstract: A method is provided for multiplying the number of copies of a target polynucleotide sequence comprising a series of primer hybridization, extending, and denaturing steps to provide an intermediate double-stranded DNA molecule containing a promoter sequence (through the use of a promoter-sequence-containing primer) incorporated upstream from the target sequence. The double-stranded DNA intermediate is then used to grow multiple RNA copies of the target sequence. The resulting RNA copies can be used as target sequences to produce further copies. Multiple cycles of this sort can thereby exponentially increase the number of target sequence copies.
    Type: Grant
    Filed: June 6, 1995
    Date of Patent: July 18, 2000
    Assignee: The Board of Trustees of the Leland Stanford Junior University
    Inventors: James Lawrence Burg, Philippe Jacques Pouletty, John Charles Boothroyd
  • Patent number: 5859196
    Abstract: Genetic material encoding p30 and B1 peptides of Toxoplasma gondii has been isolated and characterized. This genetic material allows the production of peptides for use in diagnosis or immunization or can itself be directly used in hybridization assays.
    Type: Grant
    Filed: June 5, 1995
    Date of Patent: January 12, 1999
    Assignees: Trustees of the Leland Stanford Junior University, Trustees of Dartmouth College
    Inventors: John Charles Boothroyd, James Lawrence Burg, Lloyd H. Kasper